West Pharmaceutical Services, Inc.WSTNYSE
Loading
EBITDA Over TimeStrong
Percentile Rank71
3Y CAGR-3.6%
5Y CAGR+6.9%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
-3.6%/yr
vs +23.0%/yr prior
5Y CAGR
+6.9%/yr
Recent deceleration
Acceleration
-26.6pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $723.60M | -2.7% |
| 2024 | $743.80M | -11.9% |
| 2023 | $844.10M | +4.5% |
| 2022 | $808.10M | -8.1% |
| 2021 | $879.70M | +69.5% |
| 2020 | $518.90M | +28.7% |
| 2019 | $403.20M | +14.2% |
| 2018 | $353.20M | +8.3% |
| 2017 | $326.20M | +13.7% |
| 2016 | $286.90M | - |